| Risk factors for lung cancer worldwide J Malhotra, M Malvezzi, E Negri, C La Vecchia, P Boffetta European Respiratory Journal 48 (3), 889-902, 2016 | 1086 | 2016 |
| Breast cancer after chest radiation therapy for childhood cancer CS Moskowitz, JF Chou, SL Wolden, JL Bernstein, J Malhotra, ... Journal of Clinical oncology 32 (21), 2217-2223, 2014 | 318 | 2014 |
| Current state of immunotherapy for non-small cell lung cancer J Malhotra, SK Jabbour, J Aisner Translational lung cancer research 6 (2), 196, 2017 | 222 | 2017 |
| Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers M Palmeri, J Mehnert, AW Silk, SK Jabbour, S Ganesan, P Popli, ... ESMO open 7 (1), 100336, 2022 | 208 | 2022 |
| Immune activation and benefit from avelumab in EBV-positive gastric cancer A Panda, JM Mehnert, KM Hirshfield, G Riedlinger, S Damare, ... JNCI: Journal of the National Cancer Institute 110 (3), 316-320, 2018 | 200 | 2018 |
| Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ... Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020 | 175 | 2020 |
| First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors MN Stein, JR Bertino, HL Kaufman, T Mayer, R Moss, A Silk, N Chan, ... Clinical cancer research 23 (15), 4163-4169, 2017 | 156 | 2017 |
| Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time T Ly, J Gulia, V Pyrgos, M Waga, S Shoham Therapeutics and clinical risk management 4 (3), 637-640, 2008 | 146 | 2008 |
| Non-genetic intra-tumor heterogeneity is a major predictor of phenotypic heterogeneity and ongoing evolutionary dynamics in lung tumors A Sharma, E Merritt, X Hu, A Cruz, C Jiang, H Sarkodie, Z Zhou, ... Cell reports 29 (8), 2164-2174. e5, 2019 | 125 | 2019 |
| Phase 1 trial of Pembrolizumab administered concurrently with Chemoradiotherapy for locally advanced non–small cell lung cancer: a nonrandomized controlled trial SK Jabbour, AT Berman, RH Decker, Y Lin, SJ Feigenberg, SN Gettinger, ... JAMA oncology 6 (6), 848-855, 2020 | 123 | 2020 |
| Impact of patient–provider race, ethnicity, and gender concordance on cancer screening: findings from Medical Expenditure Panel Survey J Malhotra, D Rotter, J Tsui, AAM Llanos, BA Balasubramanian, ... Cancer epidemiology, biomarkers & prevention 26 (12), 1804-1811, 2017 | 120 | 2017 |
| Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC N Yegya-Raman, K Wang, S Kim, M Reyhan, MP Deek, M Sayan, D Li, ... Journal of thoracic oncology 13 (10), 1508-1518, 2018 | 97 | 2018 |
| Montelukast in hospitalized patients diagnosed with COVID-19 AR Khan, C Misdary, N Yegya-Raman, S Kim, N Narayanan, S Siddiqui, ... Journal of Asthma 59 (4), 780-786, 2022 | 87 | 2022 |
| Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia J Malhotra, M Kremyanskaya, E Schorr, R Hoffman, J Mascarenhas Clinical Lymphoma Myeloma and Leukemia 14 (1), 31-36, 2014 | 84 | 2014 |
| Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration MN Stein, J Malhotra, RS Tarapore, U Malhotra, AW Silk, N Chan, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 69 | 2019 |
| A phase 1–2 study of rovalpituzumab tesirine in combination with nivolumab plus or minus ipilimumab in patients with previously treated extensive-stage SCLC J Malhotra, P Nikolinakos, T Leal, J Lehman, D Morgensztern, JD Patel, ... Journal of Thoracic Oncology 16 (9), 1559-1569, 2021 | 65 | 2021 |
| Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC) J Malhotra, S Jabbour, M Orlick, G Riedlinger, Y Guo, E White, J Aisner Cancer treatment and research communications 21, 100158, 2019 | 65 | 2019 |
| Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer SJ Wang, K Khullar, S Kim, N Yegya-Raman, J Malhotra, R Groisberg, ... Journal for ImmunoTherapy of Cancer 8 (2), e000889, 2020 | 52 | 2020 |
| In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells JJ Duan, W Yue, JY E, J Malhotra, S Lu, J Gu, F Xu, XL Tan Scientific reports 6 (1), 31672, 2016 | 45 | 2016 |
| Association between cigar or pipe smoking and cancer risk in men: a pooled analysis of five cohort studies J Malhotra, C Borron, ND Freedman, CC Abnet, PA Van Den Brandt, ... Cancer prevention research 10 (12), 704-709, 2017 | 44 | 2017 |
